HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Andrew V Schally Selected Research

vapreotide

1/2012Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
9/2008Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
7/2006[History of clinical studies on hypothalamic hormone analogs in Mexico].
8/2003Response of patients with advanced prostatic cancer to administration of somatostatin analog RC-160 (vapreotide) at the time of relapse.
5/2003Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238.
8/2002Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
4/2002Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Andrew V Schally Research Topics

Disease

148Neoplasms (Cancer)
06/2015 - 01/2002
48Prostatic Neoplasms (Prostate Cancer)
11/2015 - 02/2002
27Carcinoma (Carcinomatosis)
09/2014 - 02/2002
22Breast Neoplasms (Breast Cancer)
01/2015 - 12/2002
16Endometrial Neoplasms (Endometrial Cancer)
06/2012 - 09/2002
14Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2013 - 04/2004
13Ovarian Neoplasms (Ovarian Cancer)
06/2012 - 09/2002
12Neoplasm Metastasis (Metastasis)
12/2013 - 06/2002
11Glioblastoma (Glioblastoma Multiforme)
10/2014 - 09/2004
9Pancreatic Neoplasms (Pancreatic Cancer)
05/2013 - 01/2003
9Lung Neoplasms (Lung Cancer)
09/2012 - 04/2003
8Melanoma (Melanoma, Malignant)
01/2014 - 09/2004
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 05/2003
7Colonic Neoplasms (Colon Cancer)
11/2012 - 02/2002
7Lymphoma (Lymphomas)
06/2012 - 10/2004
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2007 - 04/2003
6Body Weight (Weight, Body)
11/2015 - 02/2002
6Myocardial Infarction
04/2015 - 02/2010
6Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 02/2002
6Renal Cell Carcinoma (Grawitz Tumor)
01/2013 - 08/2005
5Adenocarcinoma
06/2014 - 10/2002
4Inflammation
12/2014 - 09/2013
4Endometriosis (Adenomyosis)
07/2009 - 04/2004
4Leiomyoma (Uterine Fibroids)
06/2009 - 04/2004
4Brain Neoplasms (Brain Tumor)
08/2005 - 04/2003
3Kidney Neoplasms (Kidney Cancer)
12/2012 - 01/2004
3Liver Neoplasms (Liver Cancer)
10/2012 - 02/2005
3Carcinoid Tumor (Carcinoid)
09/2012 - 02/2005
3Urinary Bladder Neoplasms (Bladder Cancer)
07/2012 - 01/2011
3Sarcoma (Soft Tissue Sarcoma)
06/2012 - 10/2002
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2015 - 07/2010
2Heart Failure
04/2015 - 12/2014
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
02/2015 - 09/2013
2Disease Progression
11/2014 - 10/2010

Drug/Important Bio-Agent (IBA)

82Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
06/2015 - 01/2002
58Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2015 - 02/2002
46Messenger RNA (mRNA)IBA
10/2014 - 02/2002
44somatotropin releasing hormone receptorIBA
04/2015 - 06/2002
33BombesinIBA
05/2014 - 03/2002
32Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2013 - 02/2002
28Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015 - 02/2002
25HormonesIBA
06/2015 - 09/2002
25Gastrin-Releasing PeptideIBA
05/2014 - 03/2002
23AN 204 (AN 201)IBA
01/2011 - 02/2002
21LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
12/2014 - 02/2002
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2014 - 08/2002
16T 107IBA
05/2013 - 09/2002
14cetrorelix (Cetrotide)FDA Link
06/2013 - 08/2002
13Epidermal Growth Factor (EGF)IBA
10/2014 - 03/2002
13AN 238IBA
01/2011 - 02/2002
13AN 207IBA
01/2011 - 02/2002
13Insulin-Like Growth Factor I (IGF-1)IBA
02/2010 - 04/2002
12PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
06/2013 - 02/2007
12Somatostatin Receptors (Somatostatin Receptor)IBA
02/2013 - 02/2002
12AN 215IBA
01/2011 - 10/2003
11Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2008 - 08/2002
10PeptidesIBA
05/2014 - 03/2002
10Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
10/2012 - 03/2002
10Estrogens (Estrogen)FDA Link
04/2012 - 03/2002
9JV 1-38IBA
02/2013 - 08/2002
8Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
06/2015 - 11/2010
8Epidermal Growth Factor Receptor (EGF Receptor)IBA
10/2014 - 10/2003
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2013 - 08/2005
8Proteins (Proteins, Gene)IBA
04/2012 - 12/2005
7Insulin (Novolin)FDA Link
11/2015 - 11/2003
7Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2013 - 04/2002
7Growth Hormone (Somatotropin)IBA
09/2012 - 08/2002
7vapreotideIBA
01/2012 - 04/2002
7RC 121IBA
08/2010 - 02/2002
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2009 - 02/2002
6Peptide Receptors (Peptide Receptor)IBA
05/2014 - 09/2004
6CytokinesIBA
09/2013 - 05/2011
6MZ 5-156IBA
09/2012 - 07/2005
6MZ-J-7-118IBA
09/2007 - 01/2005
5K 76 carboxylic acidIBA
01/2015 - 09/2003
5Testosterone (Sustanon)FDA Link
06/2013 - 07/2006
5MZ-J-7-138IBA
04/2012 - 07/2005
5Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
10/2011 - 04/2002
4Phosphotransferases (Kinase)IBA
06/2015 - 05/2011
4JI-38IBA
02/2014 - 02/2010
4NeuropeptidesIBA
01/2013 - 01/2011
4Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
01/2012 - 03/2002
4Peptide Hormones (Polypeptide Hormones)IBA
01/2011 - 10/2005
4Protein Isoforms (Isoforms)IBA
08/2006 - 06/2002
3irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 07/2012
3Fluorouracil (Carac)FDA LinkGeneric
01/2015 - 07/2012
3docetaxel (Taxotere)FDA Link
01/2015 - 09/2006
3CytotoxinsIBA
01/2015 - 07/2012
3Carrier Proteins (Binding Protein)IBA
12/2013 - 07/2006
3Bombesin Receptors (Bombesin Receptor)IBA
01/2012 - 10/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2009 - 11/2007
3Tyrosine (L-Tyrosine)FDA Link
09/2008 - 06/2002
2Streptozocin (Streptozotocin)FDA Link
11/2015 - 07/2010
2Hypothalamic HormonesIBA
11/2015 - 01/2005
2Cisplatin (Platino)FDA LinkGeneric
01/2015 - 11/2012

Therapy/Procedure

35Drug Therapy (Chemotherapy)
01/2015 - 02/2002
23Heterologous Transplantation (Xenotransplantation)
10/2014 - 02/2002
9Castration
11/2015 - 02/2003
5Aftercare (After-Treatment)
11/2010 - 09/2002
4Injections
10/2009 - 02/2002